Sternon J
Service de Médecine Interne, Hpital Erasme, Bruxelles.
Rev Med Brux. 1996 Sep;17(4):282-6.
Presentation of three controversial drugs with unequal value and of new anticoagulation strategies. The renewal of interest in oral anticoagulants is striking; it is the consequence of the better measure of the hypocoagulability and a diminution of the risk of haemorrhage. Also as striking, is the extension of the preventive and curative indications of the low molecular weight heparins.
介绍三种价值不等的有争议药物以及新的抗凝策略。口服抗凝剂重新受到关注，这一现象引人注目；这是由于对低凝状态有了更好的测量方法，且出血风险降低。同样引人注目的是，低分子量肝素的预防和治疗适应症有所扩展。
